Question Bank › The company is outgrowing its own explanations

The company is outgrowing its own explanations

The company is outgrowing its own explanations: management keeps telling investors the reported numbers are not the busi

Calls Tested
497
Answered YES
13
Hit Rate
2.6%
rare by design

Quest Diagnostics Incorporated (DGX) — this company's answers

NO on the Q2 2021 call 2021-07-22 B+
The model's full reasoning — Q2 2021 call → NOWe need to determine if management conveys that the reported results do not represent the business as it is actually running today. The key is whether management indicates that the current business is ahead of the reported period, with concrete things already in motion. From the transcript: Steve Rusckowski says "We had another strong quarter and continued to build momentum, thanks to faster than expected recovery in our base business. Organic based testing revenues grew compared to 2019 levels in the quarter. This is the first quarter since 2019 that organic base testing revenues grew." That's about the quarter. But then he says "We are well positioned to continue our momentum and support the return to health care in the coming months, which is reflected in the outlook we have provided for the remainder of 2021." That's forward-looking. Later, Mark Guinan discusses guidance: "The low end of our outlook assumes an average of at least 20,000 COVID-19 molecular tests per day and 3,000 serology tests per day. It also assumes low single digit revenue growth in our base business in the second half of '21 versus 2019. The midpoint of our guidance assumes slightly stronger COVID-19 molecular testing volumes and a modestly faster recovery of the base business and the high end of our guidance assumes both a greater level of COVID-19 testing and the strong continued recovery in the base business." That's guidance. But is there any statement that the reported period is stale relative to the operating present? For example, they mention that COVID-19 testing volumes have stabilized and increased modestly in recent weeks due to delta variant. That is current activity. But does that mean the reported quarter's numbers are behind? They say "In recent weeks we have seen PCR volumes stabilize and begin to increase modestly." That is after the quarter ended? The quarter is Q2 2021, ended June 30. The call is July 22. So recent weeks would be early July. So they are saying that after the quarter, volumes are increasing. That could be a gap. Also, they mention "We performed an average of 57,000 COVID-19 molecular tests a day in the second quarter, well below our current capacity of approximately 300,000 tests per day." That's capacity, not current volume. They also mention "We continue to make progress on our two point strategy... We continue to execute on our M&A strategy.

← Back to the full DGX analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that the company's REPORTED RESULTS FOR THE PERIOD BEING DISCUSSED DO NOT REPRESENT THE BUSINESS THE COMPANY IS ACTUALLY RUNNING TODAY — that is, does management repeatedly or substantially indicate that the just-reported numbers describe a company that has already been left behind by what is now actually happening inside the business? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent posture: the printed period is stale relative to the operating present. Any genuine expression of this counts, and the form varies widely across industries. For example — management explaining that meaningful business, capability, or activity now in motion contributed little or nothing to the reported period because it began late in the period or just after it closed; management noting that the pace, level, or mix of business the company is currently running sits above what the period's figures show; management describing that the period carried the costs of things whose benefits have only just begun; management pointing to what the company has already become — what it can now do, what it now has, what is now committed or underway — and treating the reported numbers as a picture of the company before that; or management consistently answering questions about the future by pointing to what is already in hand, in motion, or being executed rather than to what must still be won. What matters is the DIRECTION OF THE GAP in management's own telling: the business as it stands today is ahead of the business as it appears in the reported period, and management itself is the one drawing attention to that gap, grounded in things that are already real — actual current activity, completed work, committed business, or capabilities already in place — not in hopes, plans, market size, or projections. Answer NO if the call is a conventional results-and-outlook discussion in which the reported period and the described business are essentially the same size — ordinary strength, ordinary guidance, however good. NO if the claimed gap rests mainly on pipeline, bids, negotiations, market opportunity, hoped-for demand, or initiatives with nothing concrete yet occurring. NO if the only "numbers lag the business" language is a single passing remark or boilerplate about investing for the future, with no substance about what has already changed. NO if management is chiefly defending weak results, explaining a slump, or promising a future turnaround from a trough. NO if the recent developments are routine in scale for this company — the normal cadence of wins, openings, or orders it always reports — with no sense that the business has moved to a different level than the print. NO if the gap is asserted only in an analyst's question or model that management does not itself affirm with its own account of current operations. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
KOPN Kopin Corporation Q4 2023 2024-03-14 C+
PFE Pfizer Inc. Q4 2023 2024-01-30 F
SCPH scPharmaceuticals Inc. Q3 2023 2023-11-08 B
NBTX Nanobiotix S.A. Q2 2023 2023-09-27 D
PRPH ProPhase Labs, Inc. Q1 2023 2023-05-11 F
VRE Veris Residential, Inc. Q4 2022 2023-02-22 D
SOL ReneSola Ltd Q3 2022 2022-12-01 C+
FLL Full House Resorts, Inc. Q3 2022 2022-11-07 B
OPK OPKO Health, Inc. Q1 2022 2022-05-09 D
FAT FAT Brands Inc. Q4 2021 2022-03-21 F
OWL Blue Owl Capital Inc. Q2 2021 2021-08-10 B+
PRIM Primoris Services Corporation Q2 2018 2018-08-11 C+
LIND Lindblad Expeditions Holdings, Inc. Q2 2017 2017-08-06 C

How the model reasoned

VRE · Q4 2022 → YESThe question is: Does management convey that the reported results for the period do not represent the business the company is actually running today? That the just-reported numbers describe a company ...YES The transcript shows management repeatedly framing the reported period as transitional and not reflective of the current business: the shift to a pure-play multi-family company has already reduced office and hotel exposure while driving multi-family NOI share to 98%, with Haus25 leased at 95% ahead of schedule and same-store NOI guidance of 4-6% for 2023. They explicitly note that earnings variability stems from the ongoing asset sales and reallocation, with the business now positioned for growth as the transformation concludes, and they highlight post-period activity like additional sales and stabilized properties to underscore that the reported numbers capture a pre-transition state.
PFE · Q4 2023 → YESThe question is: Does management convey that the reported results do not represent the business the company is actually running today? That the just-reported numbers describe a company that has alread...NO The transcript shows management framing 2023 results as a challenging year with declines driven by COVID products, while positioning 2024 as a year of execution and growth through new priorities like the Seagen acquisition (closed late in 2023 with minimal contribution) and new product launches. This is a standard results-and 2024 outlook discussion, with forward-looking elements on pipeline, margins, and capital allocation rather than indicating the reported period is stale relative to current operations.
PRIM · Q2 2018 → YESThe question is whether management conveys that the reported results for Q2 2018 do not represent the business the company is actually running today. Specifically, if the printed period is stale relat...YES The transcript shows management repeatedly framing the Q2 results as a partial picture due to the late June 1 acquisition of Willbros. They note the business is "running as planned," highlight one-month revenue contribution of $1.

More from the question bank

Undersized for what it has already been handMid-period crossingsSelf-authored recoveryTheir own money on the lineGrowing out of the old selfGrowing out of the old selfAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.